Resveratrol vs Pterostilbene: Which Polyphenol Is…

Resveratrol became one of the most talked-about longevity supplements in the world after researchers found it activated sirtuins—proteins linked to lifespan extension in animal models—and linked it to the "French Paradox" of red wine consumption. Pterostilbene is its lesser-known cousin from blueberries, structurally similar but with dramatically better bioavailability. Which one is actually worth your money?

The short answer

Pterostilbene is more bioavailable (~80% vs. ~20% for resveratrol) and more lipid-soluble, making it a more efficient delivery vehicle. But resveratrol has far more published human research and remains the most studied polyphenol in the longevity space. They work through the same core pathways (sirtuin activation) and have complementary effects. For budget-conscious buyers, resveratrol at higher doses is still effective; for efficiency maximizers, pterostilbene is the upgrade.

What is resveratrol?

Resveratrol is a stilbene polyphenol produced by plants under stress (fungal infection, UV damage, injury) as a protective compound. It's found in red grape skin, red wine, peanuts, and Japanese knotweed (Polygonum cuspidatum, the most common commercial source).

Natural sources: Red wine (~0.1–14mg per glass), red grape skin, peanuts, dark chocolate, Japanese knotweed
Commercial source: Most supplements use Japanese knotweed extract
Active forms: Trans-resveratrol (the biologically active form) and cis-resveratrol
Primary mechanisms: SIRT1 activation, AMPK activation, anti-inflammatory (NF-κB inhibition), antioxidant
Bioavailability: Approximately 20–50% absorbed but rapidly metabolized; free resveratrol in blood is actually quite low
Standard supplement dose: 150–500mg/day

What is pterostilbene?

Pterostilbene is resveratrol's natural analog—structurally nearly identical except for two methoxy groups where resveratrol has hydroxyl groups. It's found primarily in blueberries and grapes, but in much smaller quantities than resveratrol (hence why supplementation rather than diet is required for therapeutic doses).

Natural sources: Blueberries (trace amounts: ~99µg per gram), grapes, peanuts
Primary mechanisms: SIRT1 and SIRT3 activation, PPAR-alpha agonism (fat metabolism), anti-inflammatory, antioxidant—similar to resveratrol but with some differences in specific target affinity
Bioavailability: Approximately 80% absorbed (four times that of resveratrol)
Half-life: ~105 minutes vs. ~14 minutes for resveratrol—much longer blood retention
Lipid solubility: Higher than resveratrol, enabling better cellular penetration
Standard supplement dose: 50–150mg/day

Key differences

Bioavailability: The critical advantage of pterostilbene

The two methoxy groups that differentiate pterostilbene from resveratrol are responsible for its dramatically better pharmacokinetics:

Resveratrol is rapidly absorbed but equally rapidly metabolized and conjugated in the intestinal wall and liver (first-pass metabolism). Less than 1% of an oral dose reaches the bloodstream as free, unconjugated resveratrol. The total bioavailability when including metabolites is higher (~20–50%), but the active free form is low.
Pterostilbene resists metabolism more effectively due to its methoxy groups. It reaches the bloodstream at much higher concentrations and has a longer half-life, meaning sustained activity.

Practical implication: You need roughly 4× more resveratrol than pterostilbene to achieve comparable plasma levels of free, active polyphenol. This partially explains the price differential—you can take a lower dose of pterostilbene and get similar or better tissue exposure.

Sirtuin activation: SIRT1 vs. SIRT3

Both compounds activate sirtuins, but with different emphases:

Resveratrol is most known for SIRT1 activation—originally identified as a target by Howitz et al. (2003) in the pivotal study that launched the field. SIRT1 deacetylates transcription factors, regulates metabolism, and promotes mitochondrial biogenesis via PGC-1α.
Pterostilbene appears to activate both SIRT1 and SIRT3 more effectively at lower concentrations. SIRT3 is the primary mitochondrial sirtuin, and its activation is associated with mitochondrial function, energy metabolism, and protection from oxidative stress in mitochondria.

Note: The original Sinclair lab research on resveratrol and SIRT1 was controversial—subsequent research questioned whether resveratrol directly activates SIRT1 or does so indirectly via AMPK. Both compounds likely work through multiple redundant pathways rather than a single clean mechanism.

Anti-inflammatory effects

Both are well-documented anti-inflammatory agents via NF-κB pathway inhibition. In head-to-head comparisons:

Pterostilbene shows greater NF-κB inhibition in most cell studies, attributed to its better cellular penetration
Resveratrol has more clinical human trial evidence for inflammatory marker reduction (CRP, TNF-α, IL-6)

For established anti-inflammatory effects in humans, resveratrol's larger trial base is more convincing. For theoretical potency at the cellular level, pterostilbene has the edge.

Cognitive effects

Resveratrol: Some human trials show improved cerebrovascular function and cognitive performance in older adults. A 2019 Nutrients meta-analysis found resveratrol improved memory and cognitive function in older adults across multiple RCTs.
Pterostilbene: Preclinical data is very promising (cognitive aging and memory in rodent models), but human cognitive trials are limited. One 2014 study in peanut hull extract (containing pterostilbene) showed cognitive benefits, but pure pterostilbene human cognitive data is sparse.

Blood pressure and cardiovascular

Resveratrol: Multiple clinical trials showing modest blood pressure reduction, particularly systolic BP. A 2015 meta-analysis in Hypertension confirmed a significant effect.
Pterostilbene: The MOJO trial (2014, randomized controlled trial) tested 50mg and 100mg pterostilbene with and without piperine in adults with metabolic syndrome. The 100mg/day arm showed significant blood pressure reduction (systolic -8 mmHg). Promising but less human data than resveratrol.

Blood glucose and metabolic health

Resveratrol: Multiple trials showing improved insulin sensitivity and glucose metabolism, particularly in type 2 diabetics and metabolically unhealthy individuals. AMPK activation is a key mechanism.
Pterostilbene: PPAR-alpha agonism makes it a potentially stronger fat-metabolism regulator. Animal studies show very impressive glucose control effects. Human data is limited but the MOJO trial showed improved LDL in some arms.

Cholesterol—a unique consideration

The MOJO trial found an interesting effect: higher doses of pterostilbene (100mg/day) increased LDL cholesterol in some participants, which was unexpected and warrants attention. Resveratrol does not have this reported effect.

If you have elevated LDL or are cardiovascular risk-conscious, this finding makes resveratrol the safer choice until more data is available. Always discuss with a physician if relevant.

Human trial landscape

Resveratrol has by far the larger human evidence base:

100+ clinical trials registered and/or completed
Studied doses from 150mg to 5000mg/day
Studied in healthy adults, diabetics, cardiovascular patients, cancer patients, postmenopausal women, and cognitively declining older adults
Well-characterized safety profile at doses up to 1500mg/day

Pterostilbene has much less human data:

~10–15 published clinical trials
MOJO trial (2014) is the landmark study: 50mg and 100mg doses in adults with metabolic risk factors
Most other human trials are smaller and less definitive
Safety established at 50–350mg/day

Can you combine resveratrol and pterostilbene?

Yes, and combination products exist. The rationale is that they have complementary bioavailability profiles and slightly different sirtuin targets:

Resveratrol provides a larger dose of polyphenol at lower cost
Pterostilbene adds the longer-lasting, more bioavailable component

Sinclair's stack often discussed in his book Lifespan includes resveratrol combined with NMN; adding pterostilbene is an extension of this approach. See NMN vs NR for more on the NAD+ side of this stack.

A typical combination product might contain 100–200mg resveratrol + 50–100mg pterostilbene.

Bioavailability enhancement strategies

For resveratrol specifically, bioavailability is a known limitation. Strategies to improve it:

Take with fat: Resveratrol is lipid-soluble; taking with a meal that contains fat significantly improves absorption
Piperine (black pepper extract): Inhibits intestinal glucuronidation; some studies show 2x absorption increase with 20mg piperine
Micronized formulations: Smaller particle size improves absorption; some brands use this
Liposomal resveratrol: Encapsulation in phospholipid vesicles; limited but promising data on improved delivery
Take with NMN/NR: The Sinclair hypothesis is that NMN provides NAD+ "fuel" that allows sirtuins activated by resveratrol to function more effectively

Dosages

Resveratrol:

Minimum effective: 150mg/day (consistent with studies like Sinclair's personal protocol)
Most clinical trials: 150–500mg/day
Higher-dose trials: 1000–2000mg/day (no additional benefit over 500mg in most studies; questionable value of very high doses given the metabolism issue)
Recommendation: 250–500mg/day of trans-resveratrol with a fatty meal
Take in the morning with NMN if using that stack

Pterostilbene:

Minimum effective: 50mg/day
Clinical trial doses: 50–350mg/day
Most research cluster: 50–100mg/day
Recommendation: 50–100mg/day
Due to better bioavailability, lower doses are needed; going above 100mg/day is unlikely to add proportionate benefit

Cost comparison

Resveratrol at 250mg/day: approximately $15–30/month (widely available, price-competitive)
Pterostilbene at 50–100mg/day: approximately $25–50/month (more expensive, fewer manufacturers)
A combination product at moderate doses of both: $30–60/month

The cost-per-effective-dose ratio is relatively similar once you account for bioavailability differences, but resveratrol wins on pure affordability.

How to choose

Choose resveratrol if you: Want the supplement with the most human evidence, are budget-conscious, are stacking with NMN for sirtuin/NAD+ synergy, or are specifically targeting the cardiovascular or blood pressure effects that resveratrol has good trial data for.
Choose pterostilbene if you: Prioritize bioavailability and longer half-life, want stronger SIRT3/mitochondrial effects, are already taking resveratrol and want to upgrade, or prefer lower-dose supplementation.
Use both if you: Want comprehensive polyphenol coverage, are building a serious longevity stack, or are comfortable with the cost of combination products.
Avoid pterostilbene if you: Have elevated LDL cholesterol (the MOJO trial finding warrants caution).
Be skeptical of: Very high doses of either (>1000mg resveratrol); the dose-response flattens and there's even evidence of hormesis inversion (potential interference with exercise adaptations at very high doses).

The bottom line

Pterostilbene is the more bioavailable, more potent-per-milligram polyphenol, but resveratrol has the larger body of human evidence and a lower price point. For most people, resveratrol remains the practical starting point; pterostilbene is the upgrade for those who want maximum efficiency. Both work through the same core pathways, and combining them at moderate doses is a sensible approach for the longevity-focused supplementer.

Track your supplements and see which ones actually work for you. Use Optimize free.

Resveratrol vs Pterostilbene: Which Polyphenol Is More Effective?